5 active not recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 5 |
Follow Multiple System Atrophy: new trials by email Literature Review of Multiple System Atrophy trials Research Report on Multiple System Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy YA-101, Placebo - Multiple System Atrophy | Phase 2 | Active not recruiting | Dasher Neuroscience Inc. | 75 | 2025-03-03 | 2026-08-19 |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy TEV-56286, Placebo - Multiple System Atrophy | Phase 2 | Active not recruiting | Teva Branded Pharmaceutical Products R&D LLC | 349 | 2024-10-02 | 2026-11-05 |
| A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy ONO-2808, Placebo - Multiple System Atrophy (MSA) | Phase 2 | Active not recruiting | Ono Pharmaceutical Co., Ltd. | 92 | 2023-09-22 | 2026-10-06 |
| Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy Autologous Mesenchymal Stem Cells, Placebo - Multiple System Atrophy | Phase 2 | Active not recruiting | Mayo Clinic | 71 | 2021-12-15 | 2026-06-12 |
| A Study of Lu AF82422 in Participants With Multiple System Atrophy Lu AF82422, Placebo - Multiple System Atrophy | Phase 2 | Active not recruiting | H. Lundbeck A/S | 64 | 2021-11-16 | 2026-04-13 |
Neurodegenerative Diseases (1) · Pure Autonomic Failure (1)
Autonomic Nervous System Diseases (5) · Basal Ganglia Diseases (5) · Brain Diseases (5) · Central Nervous System Diseases (5) · Movement Disorders (5) · Nervous System Diseases (5) · Primary Dysautonomias (5) · Synucleinopathies (5) · Neurodegenerative Diseases (4)
3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole (1)
Dasher Neuroscience Inc. (1) · H. Lundbeck A/S (1) · Mayo Clinic (1) · Ono Pharmaceutical Co., Ltd. (1) · Teva Branded Pharmaceutical Products R&D LLC (1)
United States (5) · Japan (4) · France (1) · Germany (1) · Israel (1) · Italy (1) · Serbia (1) · Spain (1) · Taiwan (1)
Project Leader (1) · Wolfgang Singer, MD (1)
2023 (1)